Maryanne Lubas, DO

Fox Chase Cancer Center
Philadelphia, PA

Disclosures:

• Employment: none
• Compensation: none
• Ownership: none
• Leadership: none

Presentation(s):

• 2094 - Assessing the Safety and Efficacy of a Hypofractionated Regimen in the Treatment of Early-Stage Non-Small Cell Lung Cancer Patients with Central or Ultracentral Tumors

  Sunday, September 29, 2024
  2:45 PM – 4:15 PM ET

• 2704 - Treatment Implications of Low Compliance with Endocrine Therapy for Older Women with Early-Stage Breast Cancer

  Monday, September 30, 2024
  3:00 PM – 4:00 PM ET